I recall when John Brown visited the Habener lab in the '90's at MGH and told us that GLP-1 was "way down on the list" of incretins!
General eligibility criteria per brand disclosure include BMI 30, or BMI 27 with at least one qualifying comorbidity
16-19 and back in Vegas for HIMSS 2025, Mar
You may have started a GLP-1 medication and noticed that you feel full much sooner than usual
By focusing on both medical science and compassionate guidance, we help our clients feel supported every step of the way
"There have been so many moves this year that show Novo as a conflicted company for example, reaching a deal with Hims and then terminating the deal negotiating to acquire Metsera, exiting negotiations, and then jumping back in after a signed Pfizer deal," said Andersen